| 51 |
11698569 | Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. | 2001 Nov 7 |
1 |
| 52 |
11751447 | The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. | 2001 Dec |
1 |
| 53 |
10749132 | Association of SRD5A2 genotype and pathological characteristics of prostate tumors. | 2000 Mar 15 |
1 |
| 54 |
10794483 | TA repeat polymorphism of the 5alpha-reductase gene and breast cancer. | 2000 Apr |
1 |
| 55 |
10898110 | Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. | 2000 Jul |
1 |
| 56 |
10564874 | New frameshift mutation in the 5alpha-reductase type 2 gene in a Brazilian patient with 5alpha-reductase deficiency. | 1999 Nov 26 |
2 |
| 57 |
10586125 | Current management of androgenetic alopecia in men. | 1999 Dec |
1 |
| 58 |
9777765 | Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. | 1998 Oct |
1 |
| 59 |
9067262 | A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. | 1997 Mar 15 |
1 |
| 60 |
8630237 | Role of dihydrotestosterone in androgen action. | 1996 |
1 |
| 61 |
8723114 | Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. | 1996 May 3 |
1 |
| 62 |
8865475 | Evaluation of men on finasteride. | 1996 Aug |
1 |
| 63 |
7664265 | Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk. | 1995 Sep 15 |
1 |